Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
04/29/2010 | US20100105866 Microfluidic manipulation of fluids and reactions |
04/29/2010 | US20100105863 Method For Producing Acylated Peptides |
04/29/2010 | US20100105617 C-Terminal Attachment of Two Chemical Groups to Peptides |
04/29/2010 | US20100105089 Quantum dot biotags |
04/29/2010 | US20100104608 Reactive surgical implant |
04/29/2010 | US20100101954 Compositions, Methods, Devices, and Systems for Nucleic Acid Fractionation |
04/29/2010 | CA2742043A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
04/28/2010 | EP2178901A2 Method for purifying or detecting a target protein |
04/28/2010 | EP2178834A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
04/28/2010 | EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi) |
04/28/2010 | CN1688600B Template-fixed peptidomimetics with antibacterial activity |
04/28/2010 | CN101698681A Chimeric polypeptide with dual-targeting function and applications thereof |
04/28/2010 | CN101698680A PEG-gelchromatography combined purification method for egg yolk immunoglobulins (IgY) |
04/27/2010 | USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein |
04/27/2010 | US7705122 mTOR ligands and polynucleotides encoding mTOR ligands |
04/27/2010 | US7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
04/27/2010 | US7705118 Methods for preparing internally constrained peptides and peptidomimetics |
04/27/2010 | US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties |
04/27/2010 | US7704708 Modified mutein having mutation which causes altered steric hindrance, charge repulsion and/or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues; for use in capture and purification of biomolecules |
04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
04/27/2010 | CA2532581C Pre-cast electrophoresis slab gels from supplemented monomer solutions |
04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
04/27/2010 | CA2245379C Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo |
04/27/2010 | CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease |
04/22/2010 | WO2010045648A2 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species |
04/22/2010 | WO2010043703A1 Removal of host cell proteins |
04/22/2010 | WO2010043701A1 Clarification process |
04/22/2010 | WO2010043700A1 Clarification process at higher cell density |
04/22/2010 | WO2010043230A1 Multiligand constructs |
04/22/2010 | WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof |
04/22/2010 | US20100099855 Recombinant protein comprising starch binding domain and use thereof |
04/22/2010 | US20100099831 Solid phase immobilized trifunctional linker |
04/22/2010 | US20100099607 Casein complexes |
04/22/2010 | US20100099575 Novel polypeptide scaffolds and use thereof |
04/22/2010 | US20100099185 Method of making biologically active alpha-beta peptides |
04/22/2010 | US20100099142 Processing of Peptides and Proteins |
04/22/2010 | US20100099113 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
04/22/2010 | US20100096251 Methods and Processes for Attaching Compounds to Matrices |
04/22/2010 | US20100095749 Protein crystallizing agent and method of crystallizing protein therewith |
04/22/2010 | CA2778066A1 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species |
04/22/2010 | CA2740554A1 Multiligand constructs |
04/22/2010 | CA2739501A1 Clarification process at higher cell density |
04/22/2010 | CA2739392A1 Clarification process |
04/21/2010 | EP2177902A1 Method and system for multi-stage isoelectric focussing |
04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
04/21/2010 | EP2177528A1 Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid |
04/21/2010 | EP2176292A1 Antibody purification process by precipitation |
04/21/2010 | CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
04/21/2010 | CN1891836B Method for quantitative measurement of gene expression based on paraffin-embedded tissue specimens |
04/21/2010 | CN1763084B High purity cyclosporin A preparation method |
04/21/2010 | CN101696241A Method for inducing and extracting metallothionein from housefly larva |
04/21/2010 | CN101696238A Plant total protein extracting solution and application thereof |
04/21/2010 | CN101696236A Method for synthesizing atosiban by solid phase |
04/21/2010 | CN101696235A Daptomycin analog and full solid phase synthesis preparation method thereof |
04/21/2010 | CN101696230A Two-dimensional electrophoresis method for protein |
04/21/2010 | CA2641448A1 Synthetic antigen mimetics matrices immuno-reactive with rheumatoid arthritis auto-antibodies |
04/20/2010 | US7700745 Method for separating carbohydrate in glycoside-linkage-having compound, carbohydrate separating system, carbohydrate separating reagent kit, standard sample for carbohydrate separation, and evaluation system |
04/20/2010 | US7700744 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
04/20/2010 | US7700743 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
04/20/2010 | US7700736 PRO350 antibodies |
04/20/2010 | US7700730 Using viral capsid protein comprising RGD domain (arginine-glycine-aspartic acid) to treat and prevent cell proliferative, nervous system, autoimmune and allergic disorders |
04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
04/20/2010 | US7700723 having L-sorbosone dehydrogenase activity |
04/20/2010 | US7700571 Compositions and methods for liver growth and liver protection |
04/20/2010 | US7700553 Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization |
04/20/2010 | US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity |
04/20/2010 | US7700523 zinc finger motifs are randomised in overlapping regions and to smart libraries incorporating limited directed randomisation at selected position |
04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
04/20/2010 | US7700306 characterising a polypeptide by matrix assisted laser desorption ionization (MALDI) mass spectrometry; improving sensitivity, and can increase the number of peptides that are detected from a protein |
04/20/2010 | US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system |
04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
04/20/2010 | CA2377468C Peptide acceptor ligation methods |
04/15/2010 | WO2010042654A2 Recombinant nell protein production |
04/15/2010 | WO2010042247A1 Microfluidic devices and methods of using the same |
04/15/2010 | WO2010041742A1 Method for introducing dota |
04/15/2010 | WO2010041425A1 Method for producing a peptide |
04/15/2010 | WO2010040988A1 Purification process for fragment antibodies |
04/15/2010 | WO2010040660A1 Pseudoproline dipeptides |
04/15/2010 | WO2010040214A1 Digital microfluidic method for protein extraction by precipitation from heterogeneous mixtures |
04/15/2010 | WO2010015287A3 Template-fixed peptidomimetics |
04/15/2010 | WO2010008159A3 Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof |
04/15/2010 | US20100093982 Device and method for precipitation of peptides |
04/15/2010 | US20100093977 Altered Antibodies |
04/15/2010 | US20100093934 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
04/15/2010 | US20100093102 Mesoporous metal oxide materials for phosphoproteomics |
04/15/2010 | US20100093086 Stapled Peptides and Method of Synthesis |
04/15/2010 | US20100093059 Method for the Preparation of Sulfated Cellulose Membranes and Sulfated Cellulose Membranes |
04/15/2010 | US20100093054 Novel methods for recovery of leaf proteins |
04/15/2010 | US20100093001 Means and methods for the production of amyloid oligomers |
04/15/2010 | US20100089754 Method of measuring microparticles having nucleic acid and apparatus therefor |
04/15/2010 | US20100089753 Fluorescent detection of proteins in polyacrylamide gels |
04/15/2010 | DE102004044419B4 Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie Process for the purification of von Willebrand factor by hydroxyapatite-flow chromatography |
04/15/2010 | CA2740106A1 Digital microfluidic method for protein extraction by precipitation from heterogeneous mixtures |
04/15/2010 | CA2740079A1 Methods of making concentrated fibrinogen- and platelet-containing compositions |
04/15/2010 | CA2739608A1 Recombinant nell protein production |
04/15/2010 | CA2737675A1 Pseudoproline dipeptides |
04/14/2010 | EP2175019A2 Quasirandom structure and function guided synthesis methods |
04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |